Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study. (Q43286764)
Jump to navigation
Jump to search
scientific article published on 24 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study. |
scientific article published on 24 August 2009 |
Statements
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study (English)
John F R Robertson
Antonio Llombart-Cussac
David Feltl
John Dewar
Euan Macpherson